Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00082251
Status:
COMPLETED
Last Update Posted:
2006-11-01
First Post:
2004-05-03
Brief Title:
Safety Efficacy of a Combination Niacin ERSimvastatin in Patients With Dyslipidemia A Dose-Ranging Study - SEACOAST
Sponsor:
Kos Pharmaceuticals
Organization:
Kos Pharmaceuticals
Study Overview
Official Title:
Safety Efficacy of a Combination Niacin ERSimvastatin in Patients With Dyslipidemia A Dose-Ranging Study - SEACOAST
Status:
COMPLETED
Status Verified Date:
2006-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the effectiveness and safety of different doses of Niacin ERSimvastatin NS in subjects with elevated fat levels in their blood dyslipidemia
Detailed Description:
The purpose of this study is to compare the efficacy and safety of different doses of Niacin ERSimvastatin NS in subjects with elevated fat levels in their blood dyslipidemia
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| SEACOAST | None | None | None |